mRNA |
KPT185 |
CTRPv2 |
pan-cancer |
AAC |
0.0031 |
0.9 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.003 |
0.9 |
mRNA |
bafilomycin A1 |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.9 |
mRNA |
BMS-345541 |
CTRPv2 |
pan-cancer |
AAC |
-0.0027 |
0.9 |
mRNA |
KU-60019 |
CTRPv2 |
pan-cancer |
AAC |
0.0026 |
0.9 |
mRNA |
PI-103 |
CTRPv2 |
pan-cancer |
AAC |
0.0026 |
0.9 |
mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0025 |
0.9 |
mRNA |
HBX-41108 |
CTRPv2 |
pan-cancer |
AAC |
-0.0029 |
0.9 |
mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
0.0025 |
0.9 |
mRNA |
Irinotecan |
CCLE |
pan-cancer |
AAC |
-0.0036 |
0.9 |